Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02479932
Other study ID # 77-2015
Secondary ID
Status Completed
Phase N/A
First received June 11, 2015
Last updated March 14, 2016
Start date June 2015
Est. completion date January 2016

Study information

Verified date March 2016
Source Ataturk University
Contact n/a
Is FDA regulated No
Health authority Ministry of Health: Turkey
Study type Interventional

Clinical Trial Summary

The aim of study is to compare skin-to-delivery time and postoperative morbidity between extraperitoneal cesarean and transpirational cesarean.


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- elective cesarean

- previous cesarean (<4)

- cesarean for distocia

Exclusion Criteria:

- emergency cesarean ( fetal distress)

- risk of obstetrical bleeding

- maternal coagulation defects

- adnexial mass

- uterin myoma at incision site

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Transperitoneal cesarean technique
Pfannenstiel-Kerr technique for laparatomy and uterine entry
Extraperitoneal cesarean technique
Pfannenstiel incision, paravesical approach to lower uterine segment extraperitoneally and Kerr incision for uterine entry

Locations

Country Name City State
Turkey Atatürk Üniversitesi Arastirma Hastanesi Erzurum

Sponsors (1)

Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Skin-to-delivery time 1 minute after delivery No
Secondary Postoperative pain Pain will be measured by VAS 24 and 48 hour after cesarean No
Secondary Operation time skin-to-skin operation time Two minutes after surgery No
Secondary Hemoglobin differences One hour before cesarean and 48 hours after cesarean No
Secondary Need for analgesic All analgesic given after cesarean at hospital 24 and 48 hours after cesarean No
Secondary Nausea Nausea during surgery and after surgery Two minutes and 48 hours after cesarean No
Secondary Vomiting Nausea during and after surgery Two minutes and 48 hours after cesarean No
Secondary Thoracic shoulder pain Thoracic shoulder pain after surgery 48 hours after cesarean No
Secondary Urogenital distress measured by Urogenital Distress Inventory One hour before cesarean and 24 hours after cesarean No
Secondary Oral intake The percentage of patients who tolerates oral intake. Oral intake will be allowed 4-6 hours after cesarean for extraperitoneal group. For intraperitoneal group it will be allowed when patient passed gas. 12 and 24 hours postoperatively No
Secondary Anxiety during surgery Intense fear or anxiety during surgery without pain (yes or no) One minute after cesarean No
Secondary Pain during surgery Abdominal pain during surgery (yes or no) One minutes after surgery No
See also
  Status Clinical Trial Phase
Completed NCT03539562 - Therapeutic Rest to Delay Admission in Early Labor: A Prospective Study on Morphine Sleep
Withdrawn NCT04662450 - Evaluation and Management of Parturients' Pain Intensity N/A
Completed NCT02885350 - Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour Phase 4
Completed NCT02550262 - Programmed Intermittent Epidural Bolus for Labor Analgesia During First Stage of Labor N/A
Completed NCT01598506 - Intrathecal Hydromorphone for Labor Analgesia Phase 2
Withdrawn NCT01636999 - Comparing Sedara to Butorphanol in Early Labor N/A
Completed NCT00987441 - Epidural Labor Analgesia and Infant Neurobehavior N/A
Completed NCT00755092 - Effect of Doula in Nulliparas and Multiparas N/A
Terminated NCT00787176 - The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes N/A
Recruiting NCT06036797 - Efficacy and Safety of Hydromorphone-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia Phase 2
Completed NCT05512065 - Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women N/A
Completed NCT05327088 - Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia Phase 2
Completed NCT03103100 - Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation Phase 3
Recruiting NCT03623256 - Comparison of Intrathecal Versus Epidural Fentanyl on Fetal Bradycardia in Labor Combined Spinal Epidural Analgesia Phase 4
Active, not recruiting NCT02271100 - Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique N/A
Completed NCT02926469 - Virtual Reality Analgesia in Labor: The VRAIL Pilot Study N/A
Completed NCT03712735 - Programmed Intermittent Epidural Bolus For Laboring Obstetrical Women Phase 4
Not yet recruiting NCT05565274 - Outcome of Combined Tramadol and Paracetamol Versus Pentazocine as Labour Analgesia Among Parturients N/A
Recruiting NCT02575677 - Oxycodone in Treatment of Early Labour Pain Efficacy and Safety
Recruiting NCT01708668 - The Effects of Intermittent Epidural Bolus on Fever During Labor Analgesia N/A